Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Muscle-Building supplement tested for COVID-19 patients with liver disease

NCT ID NCT04858412

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 18 times

Summary

This study looks at whether a supplement called HMB (a natural substance related to the amino acid leucine) can help reverse muscle loss in people who have both alcoholic liver disease and COVID-19 pneumonia. About 48 participants will take the supplement and be monitored for changes in muscle mass and hospital visits over 90 days. The goal is to see if HMB can improve recovery and reduce serious complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 PNEUMONIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cleveland Clinic Foundation

    RECRUITING

    Cleveland, Ohio, 44195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.